Canton Hathaway’s Edwards Lifesciences EW Stock Holding History

Canton Hathaway’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-225	Closed	-$21K	–	255
2024 Q2	$21K	Hold	225	–	–	0.01%	235
2024 Q1	$22K	Sell	225 -90	-29%	-$7.56K	0.01%	238
2023 Q4	$24K	Hold	315	–	–	0.01%	218
2023 Q3	$22K	Hold	315	–	–	0.01%	213
2023 Q2	$30K	Hold	315	–	–	0.01%	191
2023 Q1	$26K	Hold	315	–	–	0.01%	205
2022 Q4	$24K	Hold	315	–	–	0.01%	210
2022 Q3	$26K	Hold	315	–	–	0.01%	195
2022 Q2	$30K	Hold	315	–	–	0.01%	207
2022 Q1	$37K	Hold	315	–	–	0.01%	204
2021 Q4	$41K	Hold	315	–	–	0.01%	207
2021 Q3	$36K	Buy	+315	New	+$36K	0.01%	216
2021 Q2	–	Sell	-90	Closed	-$8K	–	271
2021 Q1	$8K	Hold	90	–	–	﹤0.01%	246
2020 Q4	$8K	Hold	90	–	–	﹤0.01%	217
2020 Q3	$7K	Hold	90	–	–	﹤0.01%	266
2020 Q2	$6K	Buy	+90	New	+$6.4K	﹤0.01%	146
2020 Q1	–	Sell	-1,290	Closed	-$100K	–	162
2019 Q4	$100K	Hold	1,290	–	–	0.05%	103
2019 Q3	$95K	Hold	1,290	–	–	0.05%	104
2019 Q2	$79K	Buy	1,290 +90	+8%	+$5.44K	0.04%	108
2019 Q1	$76K	Hold	1,200	–	–	0.04%	108
2018 Q4	$61K	Hold	1,200	–	–	0.04%	103
2018 Q3	$70K	Buy	+1,200	New	+$58.7K	0.04%	88

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Canton Hathaway's EW Position: Q3 2024 in Review

Canton Hathaway sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 225 shares — an estimated $21K sold.

Canton Hathaway first reported a position in EW in Q3 2018 and held it in 22 quarters. The position peaked at $100K in Q4 2019. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

Canton Hathaway reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
Canton Hathaway sold 225 Edwards Lifesciences shares in Q3 2024, an estimated $21K.
Canton Hathaway first reported a position in Edwards Lifesciences in Q3 2018 and held it in 22 quarters.
Canton Hathaway's Edwards Lifesciences position peaked at $100K in Q4 2019.
1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Canton Hathaway's 13F filing for Q3 2024, filed 13 Nov 2024.